BOTOX® Treatment in Pediatric Lower Limb Spasticity: Open-label Study
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Muscle spasticity
- Focus Adverse reactions; Registrational
- Sponsors Allergan
- 05 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 05 Oct 2017 Planned End Date changed from 1 Aug 2018 to 31 Aug 2018.
- 05 Oct 2017 Planned primary completion date changed from 1 Aug 2018 to 31 Aug 2018.